12th Annual Meeting on Collaborative Registration Procedure (CRP): Reliance through Facilitated Product Introduction
JS Luwansa Hotel
The Annual Meeting on the Collaborative Registration Procedure (CRP) is organized to support accelerated national registration of prequalified medicines, vaccines, in-vitro diagnostics (IVDs), and products approved by the "Stringent Regulatory Authorities (SRA)”.
Essentially, the accelerated registration for WHO-prequalified products and SRA-approved medicines in participating countries is through the reliance on shared confidential assessment or inspection reports with regulatory focal points at the manufacturers' request.
The 12th Annual CRP Meeting will be held in Jakarta, Indonesia between 12 and 14 November 2024. The venue for the meeting is the JS Luwanka, located in the city center of Jakarta, on Jl. HR Rasuna Said, which give you access to all major offices building and the Toll way.
Keep an eye out for updates and additional information regarding this important event.
- 1- CRP 12th Annual Meeting Introduction and recommendations combined.pdf
- Plenary 1 Perspectives from WHO and partners - Combined presentation for sharing 12 Nov 24.pdf
- Plenary 2_Perspectives from National Regulatory Authorities and Industry - Intro.pdf
- Update Session - CRP Progress and way forward Consolidated Slides.pdf
-
-
1
Arrival of participants and Registration to CRP Annual Meeting
Facilitator: Alexandre Buffin, WHO/FPI
-
Opening Session: Keynote address
Rapporteur: Nyasha Maregere / Ana Rita Nogueira / Chloe Michelon
Convener: Marie Anne Nicole Daniele Valentin (WHO)-
2
Remarks from REG Unit Head
Recorded Video
Speaker: Hiiti sillo (WHO/REG) - 3
-
2
-
Interactive Open to WHO, NRAs, SRAs and Industry: Warm-up exercise for participants in the room: Introduction of participants. Online participants can have a 30-minute coffee break
Rapporteur: Nyasha Maregere / Ana Rita Nogueira / Chloe Michelon
Convener: Marie Anne Nicole Daniele Valentin (WHO) -
Update/Briefing Session: Open to WHO, NRAs, SRAs and Industry: Overview
Rapporteur: Nyasha Maregere / Ana Rita Nogueira / Chloe Michelon
Convener: Marie Anne Nicole Daniele Valentin (WHO)- 4
-
5
CRP Overview
Overview of Facilitated Regulatory Pathways and Introduction of CRP principles, and high-level implementation of recommendations from 11th Annual CRP meeting
Speaker: Marie Anne Nicole Daniele Valentin (WHO)
-
10:30
Morning Coffee Break & Group Photo
-
Update/Briefing Session: Open to WHO, NRAs, SRAs and Industry: CRP: Progress and Achievements
Rapporteur: Nyasha Maregere / Ana Rita Nogueira / Chloe Michelon
- 6
- 7
- 8
-
9
"Questions from participants" on the different product streamsSpeakers: Agnes Sitta Kijo (WHO), Nyasha Lizzie MAREGERE, Sunday kisoma (WHO)
-
Interactive Open to WHO, NRAs, SRAs and Industry: Q&A
Rapporteur: Nyasha Maregere / Ana Rita Nogueira / Chloe Michelon
Convener: Marie Anne Nicole Daniele Valentin (WHO) -
12:30
Lunch
-
Interactive Open to WHO, NRAs, SRAs and Industry: Plenary 1
Rapporteur: Nyasha Maregere / Ana Rita Nogueira / Chloe Michelon
Convener: Marie Anne Nicole Daniele Valentin (WHO)-
10
Perspectives of WHO and partners - High level panel on Facilitated Regulatory Pathways and CRP
- Principles and efficiencies of facilitated regulatory pathways and CRP, and the role of WHO
- WLA and linkages to facilitated regulatory pathways and CRP
Short Interventions/presentations: 10 min for each speaker + 10 min moderator
Speakers: Alireza Khadem Broojerdi (WHO), Ann Egede Ottosen (UNICEF), Lawrence Nzumbu, Murray Lumpkin (Bill & Melinda Gates Foundation), Olivier LAPUJADE (WHO), Susie Braniff (WHO), Victoria Palmi (EMA)
-
10
-
15:10
Afternoon Coffee Break
-
Interactive Open to WHO, NRAs, SRAs and Industry: Plenary 2
Rapporteur: Nyasha Maregere / Ana Rita Nogueira / Chloe Michelon
Convener: Sunday kisoma (WHO)-
11
Perspectives of NRAs and Industry - Facilitating national medical products registration through Collaborative registration procedure (CRP)
- Reflections on experience of CRP implementation and added value to regulatory processes.
- Regulatory convergence and harmonization as experienced in CRP implementation
- What works best and areas that require improvements to the procedure
- Proposals/Recommendations for CRP improvement and expansion
- Discussions, Question and Answers
Short Interventions/presentations: 8 minutes for each speaker and 10 minutes for question and answers
Speakers: Clifford Shadreck Mwale (The Pharmacy and Medicines Regulatory Authority, Malawi), Eddie Wang, FIKRIYE HANDAN OZTUNCA (Turkish Medicines And Medical Devices Agency), Janis Bernat (International Federation of Pharmaceutical Manufacturers and Associations), PQ CRP Industry - DCVMN (TBC), Thabo Bryan Bokhutlo (Botswana)
-
11
-
Closing Session: End of Day 1
Rapporteur: Nyasha Maregere / Ana Rita Nogueira / Chloe Michelon
-
19:00
Reception
Dinner and Karaoke (each delegation "is invited" to seing a song from their country)
Facilitator: Alexandre Buffin, WHO/FPI
-
1
-
-
Interactive Closed Session: Group 1 NRAs: CRP for Medicines, Vaccines and Biotherapeutics
Rapporteur: Nyasha Maregere / Ana Rita Nogueira / Chloe Michelon
Convener: Sunday kisoma (WHO)-
12
Overview of CRP pathways and implementation
-
Overview of SRA review process for MAAs and PACs, reliance policies and practices – EMA (20 minutes)
-
Overview of SRA review process, reliance policies and practices – TGA (20 minutes)
-
Overview of SRA review processes, reliance policies and practices – PMDA (20 minutes)
-
Overview of WHO/PQT review processes, reliance policies and practices – WHO/PQT (30 minutes)
-
Question and Answers (10 minutes)
-
Tools to facilitate implementation of CRP by NRAs – WHO/FPI (20 minutes)
-
NRA experience, best practices, procedures, and tools for CRP implementation – Thailand (30 minutes)
-
NRA experience, best practices, procedures, and tools for CRP implementation – Zambia (30 minutes)
-
Question and Answers (10 minutes)
Speakers: Ayumi Endo (Pharmaceuticals and Medical Devices Agency, Japan), Lawrence Nzumbu, Natasha Brockwell (TGA), Nyasha Lizzie MAREGERE, Sakeni Hadebe (Zambia), Tharnkamol Chanprapaph (Thailand), Victoria Palmi Reig (Netherlands (Kingdom of the)), Yuriko Takemura -
-
12
-
Interactive Closed Session: Group 2 NRAs: CRP for In-Vitro Diagnostics
Rapporteur: Nyasha Maregere / Ana Rita Nogueira / Chloe Michelon
Convener: Agnes Sitta Kijo (WHO)-
13
Overview of PQ IVDs pathways and implementation
-
Introduction to the session: Moderator (10 minutes)
-
Overview of PQ IVD approaches, pathways, and tools in the assessments of products and resources (60 minutes)
-
Overview of tools to support CRP implementation – CRP steps, guidelines, and templates available for Product dossier verification and Abridged assessments and verification of sameness (online system, shared point, other reference documents) (60 minutes)
-
NRA product verification and abridged assessment application processing and product dossier verification and Abridged assessments – (90 minutes, 45 minutes each)
-
Q & A and recommendations – All (20 minutes)
Speakers: Cassiano C. Joao ANARME (Mozambique), Grace Uwanyasagani (Rwanda FDA), Jeniva Rugaiza (WHO), Susie Braniff (WHO) -
-
13
-
13:00
Lunch
-
Interactive Open to WHO, NRAs, SRAs and Industry: PQ GMP inspections
Rapporteur: Nyasha Maregere / Ana Rita Nogueira / Chloe Michelon
Convener: Sunday kisoma (WHO)-
14
Overview of PQ GMP inspections
-
Overview of PQ GMP inspections approaches, pathways, and tools (PQ inspections) –
30 minutes -
Q &A and QUIZ/ simulation exercise for NRAs – 40 minutes
-
NRA example and experience – 20 minutes
Speakers: Lilit Gharzaryan (Armenian Medical Products Regulatory Authority, Armenia), Stephanie Croft (Speaker) -
-
14
-
16:00
Afternoon Coffee Break
-
Interactive Open to WHO, NRAs, SRAs and Industry: Group Session Outcomes
Rapporteur: Nyasha Maregere / Ana Rita Nogueira / Chloe Michelon
Convener: Adrien Inoubli (WHO)-
15
Presentations of Group Session Outcomes
- Group 1 – 15 min
- Group 2 – 15 min
- Q&A – 30 min
Speakers: Cassiano C. Joao ANARME (Mozambique), Endo Ayumi (Pharmaceutical and Medical Devices Agency (PMDA), Japan), Grace Uwanyasagani (Rwanda FDA), Jeniva Rugaiza (WHO), Lawrence Nzumbu, Natasha Brockwell (TGA), Nyasha Lizzie MAREGERE, Sakeni Hadebe (Zambia), Susie Braniff (WHO), Tharnkamol Chanprapaph (Thailand), Victoria Palmi Reig (Netherlands (Kingdom of the)), Yuriko Takemura
-
15
-
Closing Session: End of the Day 2
Rapporteur: Nyasha Maregere / Ana Rita Nogueira / Chloe Michelon
-
-
-
Interactive Closed Session: CRP Clinics: One on one Interactions with NRAs
Rapporteur: Nyasha Maregere / Ana Rita Nogueira / Chloe Michelon
Convener: Marie Anne Nicole Daniele Valentin (WHO)-
16
1 on 1 meetings with registered NRAs (participating and non-participating): discussions, questions, and answers: 10 minutes per NRA
Stream 1: PQ CRP Mx/Vx
Stream 2: SRA CRP
Stream 3: PQ CRP IVDs
Stream 4: PQ CRP/SRA CRP for French Speaking countriesSpeakers: Agnes Sitta Kijo (WHO), Ana Rita GODINHO DA COSTA NOGUEIRA (WHO), Nyasha Lizzie MAREGERE, Sunday kisoma (WHO)
-
16
-
10:30
Morning Coffee Break
-
Update/Briefing Session: Open to WHO, NRAs, SRAs and Industry: ePQS
Rapporteur: Nyasha Maregere / Ana Rita Nogueira / Chloe Michelon
Convener: Agnes Sitta Kijo (WHO)-
17
ePQS: new centralized platform for CRP applications
- Interface outlook and functions for NRAs and Applicants – 10 minutes
- Instructions for stakeholders' registration in the platform – 10 minutes
- Discussion, Question and Answers – 20 minutes
Speaker: Ana Rita GODINHO DA COSTA NOGUEIRA (WHO)
-
17
-
Update/Briefing Session: Open to WHO, NRAs, SRAs and Industry: Collaborative registration procedures for medical products
Rapporteur: Nyasha Maregere / Ana Rita Nogueira / Chloe Michelon
-
18
Good practices of national regulatory authorities in implementing the CRP for medical products – Updated guideline
- Presentation on updated guideline - 20 minutes
- Discussion, Question and Answers - 10 minutes
Speaker: Agnes Sitta Kijo (WHO)
-
18
-
Update/Briefing Session: Open to WHO, NRAs, SRAs and Industry: CRP VCP
Rapporteur: Nyasha Maregere / Ana Rita Nogueira / Chloe Michelon
-
19
Update on the CRP VCP Pilot and presentation of the CRP VCP Guideline
- Presentation on updated guideline - 15 minutes
- Discussion, Question and Answers - 5 minutes
Speaker: Marie Anne Nicole Daniele Valentin (WHO)
-
19
-
12:30
Lunch
-
Interactive Open to WHO, NRAs, SRAs and Industry: Post Approval Changes
Rapporteur: Nyasha Maregere / Ana Rita Nogueira / Chloe Michelon
Convener: Marie Anne Nicole Daniele Valentin (WHO)-
20
PAC: Procedure and management
- PAC Procedure for PQ CRP: Mx/Vx/IVD (and proposals) – 10 minutes
- PAC Procedure for SRA CRP (and proposals) – 10 minutes
- NRAs experience of PAC management for PQ and SRA CRP – 20 minutes
- Recommendations from Industry (IFPMA) – 20 minutes
- Discussion, Question and Answers – 30 minutes
Presentations followed by examples of NRAs and Q&A
Speakers: Evelyn Aseawa Paintsil (Food and Drugs Authority, Ghana), Janis Bernat (International Federation of Pharmaceutical Manufacturers and Associations), Nyasha Lizzie MAREGERE, RICHARD KASONOGO (Tanzania (United Republic of)), Sunday kisoma (WHO)
-
20
-
Closing Session: Closing plenary: Meeting summary, recommendations, and way forward (20 min) and Closing remarks (10 min)
Rapporteur: Nyasha Maregere / Ana Rita Nogueira / Chloe Michelon
Convener: Marie Anne Nicole Daniele Valentin (WHO) -
15:30
Afternoon Coffee Break
-
Closing Session: End of Day 3
Rapporteur: Nyasha Maregere / Ana Rita Nogueira / Chloe Michelon
-